FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157: Experimental Peptide Creates Risk for Athletes